A clinical researcher, who has studied the lack of hygiene practices among hospital patients, is urging not just hospitals—but those who end up there—to do more to fight against the novel coronavirus, which had infected more than 2 million people worldwide by mid-April.

For the first time, instead of working together on campus, all 185 first-year students from Case Western Reserve University’s School of Medicine are using Microsoft HoloLens and the university’s signature HoloAnatomy mixed-reality software, despite the physical separation created by the COVID-19 pandemic.

University Hospitals announced it will lead a clinical trial that involves the administration of an investigational drug, ARMS-I, to its caregivers working on the frontlines of the COVID-19 pandemic. The trial, named the ARMS-I COVID Study, is designed to assess whether the drug helps prevent airborne transmission of coronavirus and whether it reduces the symptoms of healthcare providers who have tested positive for the virus.